Total Payments
$160,734
2024 Payments
$99,398
Companies
10
Transactions
174
Payment Breakdown by Category
Other$99,888 (62.1%)
Consulting$41,868 (26.0%)
Travel$14,168 (8.8%)
Food & Beverage$4,750 (3.0%)
Education$60.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,988 | 26 | 55.4% |
| Consulting Fee | $41,868 | 16 | 26.0% |
| Travel and Lodging | $14,168 | 46 | 8.8% |
| Honoraria | $10,900 | 7 | 6.8% |
| Food and Beverage | $4,750 | 77 | 3.0% |
| Education | $60.00 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $120,805 | 107 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $19,555 | 24 | $0 (2024) |
| Horizon Therapeutics plc | $12,460 | 21 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,142 | 5 | $0 (2024) |
| Amgen Inc. | $2,025 | 3 | $0 (2024) |
| Eton Pharmaceuticals, Inc. | $1,050 | 3 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $498.73 | 6 | $0 (2024) |
| PTC Therapeutics, Inc. | $139.42 | 2 | $0 (2024) |
| Chiesi USA, Inc. | $43.75 | 2 | $0 (2023) |
| Amicus Therapeutics, Inc. | $15.87 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99,398 | 89 | GENZYME CORPORATION ($88,987) |
| 2023 | $40,374 | 46 | GENZYME CORPORATION ($28,184) |
| 2022 | $10,728 | 28 | Horizon Therapeutics plc ($5,868) |
| 2021 | $8,713 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($4,075) |
| 2020 | $1,520 | 1 | Horizon Therapeutics plc ($1,520) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,152.00 | General |
| Category: Genetic Disease | ||||||
| 12/03/2024 | Amgen Inc. | RAVICTI (Biological) | Food and Beverage | In-kind items and services | $74.82 | General |
| Category: Metabolic Disorders/Rare Disease | ||||||
| 12/02/2024 | Ultragenyx Pharmaceutical Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 11/13/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $259.96 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $244.67 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $156.12 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | In-kind items and services | $109.38 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: Genetic Disease | ||||||
| 11/12/2024 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,684.00 | General |
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $800.70 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $469.58 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $388.41 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $110.23 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | In-kind items and services | $73.45 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | Cash or cash equivalent | $43.80 | General |
| Category: Genetic Disease | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: GENETIC DISEASE | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $407.96 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $358.65 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | In-kind items and services | $241.23 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $126.40 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | Cash or cash equivalent | $37.58 | General |
| Category: Genetic Disease | ||||||
About Dr. Joshua Baker, D.O
Dr. Joshua Baker, D.O is a Clinical Genetics (M.D.) healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1134534597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Baker, D.O has received a total of $160,734 in payments from pharmaceutical and medical device companies, with $99,398 received in 2024. These payments were reported across 174 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($88,988).
Ad
Practice Information
- Specialty Clinical Genetics (M.D.)
- Location Chicago, IL
- Active Since 06/24/2014
- Last Updated 06/25/2020
- Taxonomy Code 207SG0201X
- Entity Type Individual
- NPI Number 1134534597
Products in Payments
- XENPOZYME (Biological) $77,414
- RAVICTI (Drug) $12,460
- Dojolvi (Drug) $9,479
- DOJOLVI (Drug) $8,076
- CERDELGA (Drug) $6,802
- RAVICTI (Biological) $2,025
- Palynziq (Drug) $468.21
- CEREZYME (Biological) $187.59
- ELAPRASE (Biological) $67.15
- NEXVIAZYME (Biological) $64.62
- ELFABRIO (Drug) $43.75
- CARGLUMIC ACID (Drug) $25.77
- NITISINONE (Drug) $23.99
- Pombiliti (Drug) $15.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Genetics (M.D.) Doctors in Chicago
Barbara Burton, Md, MD
Clinical Genetics (M.D.) — Payments: $1.0M
Clinical Genetics (M.D.) $1.0M
Mr. Jeffrey Dungan, M.d, M.D
Clinical Genetics (M.D.) — Payments: $3,875
Clinical Genetics (M.D.) $3,875
Dr. Susan Echiverri, M.d, M.D
Clinical Genetics (M.D.) — Payments: $1,759
Clinical Genetics (M.D.) $1,759
Miguel Barajas, Md, MD
Clinical Genetics (M.D.) — Payments: $778.43
Clinical Genetics (M.D.) $778.43
Andrew Wagner, Md, MD
Clinical Genetics (M.D.) — Payments: $156.32
Clinical Genetics (M.D.) $156.32
Dr. Edward Jones, Md, MD
Clinical Genetics (M.D.) — Payments: $124.98
Clinical Genetics (M.D.) $124.98